Creation and assessment of a predictive model utilizing choroid plexus imaging from brain MRI for evaluating anti-TNF-α treatment responses in Crohn’s disease - Top-Institutions - MDSpire

Creation and assessment of a predictive model utilizing choroid plexus imaging from brain MRI for evaluating anti-TNF-α treatment responses in Crohn’s disease

  • By

  • Mengting Huang

  • Shuo Huang

  • Qinyue Luo

  • Yuting Zheng

  • Hanting Li

  • Ping Han

  • Liangru Zhu

  • Heshui Shi

  • March 6, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Neuroradiology
    • Neuroimmunology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Gastroenterology
    • Neuroradiology
    • Immunology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Gastroenterology
    • Neuroimmunology
    • Radiology

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Gastroenterology
    • Neuroradiology
    • Immunology

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Gastroenterology
    • Neuroimaging
    • Immunology

Original Source(s)

Creation and assessment of a predictive model utilizing choroid plexus imaging from brain MRI for evaluating anti-TNF-α treatment responses in Crohn’s disease

  • by Mengting Huang, Shuo Huang, Qinyue Luo, Yuting Zheng, Hanting Li, Ping Han, Liangru Zhu, Heshui Shi

  • March 6, 2026

Related Content

Factors Linked to Moderate-to-Severe Ulcerative Colitis: Insights from a Retrospective Case-Control Analysis

Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment

Proton Pump Inhibitors and Cancer Risk

Investigators evaluate cancer risk tied to extended acid suppression therapy.